B A Schwetz1. Show Affiliations » 1. Food and Drug Administration, USA.
Abstract
Mesh: See more » AIDS-Related Opportunistic Infections/drug therapyAntiviral Agents/therapeutic useAristolochic AcidsArrhythmias, Cardiac/chemically inducedCytomegalovirus Retinitis/drug therapyDietary Supplements/adverse effectsDrug LabelingGanciclovir/analogs & derivativesGanciclovir/therapeutic useHumansKidney Diseases/chemically inducedMethadyl Acetate/adverse effectsNarcotics/adverse effectsOpioid-Related Disorders/drug therapyPhenanthrenes/adverse effectsPhytotherapyProdrugs/therapeutic useUnited StatesUnited States Food and Drug AdministrationValganciclovir
Substances: See more » Antiviral AgentsAristolochic AcidsNarcoticsPhenanthrenesProdrugsaristolochic acid IValganciclovirMethadyl AcetateGanciclovir
Year: 2001 PMID: 11386912
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272